Trial Profile


Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2009

At a glance

  • Drugs Nitazoxanide; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms OPTIMA HCN2
  • Sponsors Romark Laboratories
  • Most Recent Events

    • 28 Feb 2009 New source identified and integrated (Romark media release). Interim results presented at 19th Conference of Asia Pacific Association for the Study of the Liver.
    • 31 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top